{"filing":{"accession_number":"0001178913-26-004826","cik":"0001801834","ticker":"PRFX","company_name":"PRF Technologies Ltd.","form":"6-K","filing_date":"2026-10-23","report_date":"2026-10-23","primary_document":"zk2636257.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1801834/000117891326004826/zk2636257.htm"},"events":[{"id":37479,"run_id":34547,"accession_number":"0001178913-26-004826","anchor_item_number":"EX-99.1","event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.65,"summary":"This shareholder letter discloses multiple material developments: (1) preliminary unaudited financial position as of September 30, 2026 ($11.0M cash, $2.5M liabilities, $3.7M operating loss for nine months); (2) $10.5M raised through equity line facility; (3) LayerBio's planned Phase 2 trial enrollment of OcuRing™-K before year-end; and (4) GridFeed's establishment as a standalone subsidiary with entry into AI data center power optimization. While the financial metrics are preliminary and unaudited, the combination of capital raise, clinical trial advancement, and strategic restructuring (GridFeed subsidiary formation) constitutes material disclosure affecting investor assessment. However, the event does not fit neatly into a single taxonomy category—it is neither a discrete earnings release (preliminary, unaudited, not a complete financial statement), nor a periodic report (it is a shareholder letter), nor a single operational or financial event. The domain is mixed (financial position, clinical progress, strategic restructuring), making `other_material` the most appropriate classification.","company_name":"PRF Technologies Ltd.","ticker":"PRFX","filing_date":"2026-10-23","form":"6-K","submitted_at":null,"items":[{"id":42206,"accession_number":"0001178913-26-004826","item_number":"EX-99.1","item_title":"exhibit_99-1.htm","event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.65,"reasoning":"This shareholder letter discloses multiple material developments: (1) preliminary unaudited financial position as of September 30, 2026 ($11.0M cash, $2.5M liabilities, $3.7M operating loss for nine months); (2) $10.5M raised through equity line facility; (3) LayerBio's planned Phase 2 trial enrollment of OcuRing™-K before year-end; and (4) GridFeed's establishment as a standalone subsidiary with entry into AI data center power optimization. While the financial metrics are preliminary and unaudited, the combination of capital raise, clinical trial advancement, and strategic restructuring (GridFeed subsidiary formation) constitutes material disclosure affecting investor assessment. However, the event does not fit neatly into a single taxonomy category—it is neither a discrete earnings release (preliminary, unaudited, not a complete financial statement), nor a periodic report (it is a shareholder letter), nor a single operational or financial event. The domain is mixed (financial position, clinical progress, strategic restructuring), making `other_material` the most appropriate classification.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-10-23T13:18:39.803663+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":42206,"accession_number":"0001178913-26-004826","item_number":"EX-99.1","item_title":"exhibit_99-1.htm","event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.65,"reasoning":"This shareholder letter discloses multiple material developments: (1) preliminary unaudited financial position as of September 30, 2026 ($11.0M cash, $2.5M liabilities, $3.7M operating loss for nine months); (2) $10.5M raised through equity line facility; (3) LayerBio's planned Phase 2 trial enrollment of OcuRing™-K before year-end; and (4) GridFeed's establishment as a standalone subsidiary with entry into AI data center power optimization. While the financial metrics are preliminary and unaudited, the combination of capital raise, clinical trial advancement, and strategic restructuring (GridFeed subsidiary formation) constitutes material disclosure affecting investor assessment. However, the event does not fit neatly into a single taxonomy category—it is neither a discrete earnings release (preliminary, unaudited, not a complete financial statement), nor a periodic report (it is a shareholder letter), nor a single operational or financial event. The domain is mixed (financial position, clinical progress, strategic restructuring), making `other_material` the most appropriate classification.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-10-23T13:18:39.803663+00:00","company_name":"PRF Technologies Ltd.","ticker":"PRFX","filing_date":"2026-10-23"}]}